Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Update Il y a 4 ans
Reference: NCT01191086

Woman and Man

Extract

The purpose of this study is to examine the safety of USL255 as adjunctive therapy in patients with refractory partial onset-seizures.


Inclusion criteria

  • Epilepsy